secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001628280-23-037818
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners Q3 revenue $288.4M (+16% YoY); net loss narrows; guides for positive 2024 Adj EBITDA
--------------------------------------------------------------------------------

- Q3 total revenue $288.4M, up 16% YoY; net loss $37.3M vs. $65.3M loss prior year.
- Adjusted EBITDA loss $22.3M, improved from $40.3M loss YoY; medical margin $36.2M, +306%.
- YTD total revenue $919.5M (+16%); net loss $117.3M vs. $1,029.2M loss (incl. $851M goodwill impairment).
- Reaffirms FY 2023 guidance: revenue $1.2B-$1.25B, Adj EBITDA loss $(50)-$(30)M; MA members 115k-120k.
- Preliminary FY 2024 Adj EBITDA guidance of +$20M to +$40M, signaling expected profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828023037818/0001628280-23-037818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828023037818/piii-20231108.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-037818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer